SC 13G
Amended Statement of Ownership
XBiotech Inc. Filed Acc 0001171843-16-007906
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| John Simard | 7,693,267 | 23.09% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-01-23 SCHEDULE 13G/A · W. Thorpe McKenzie 9.76%
- 2026-01-23 SCHEDULE 13G/A · John Simard 17.7%
- 2025-01-27 SCHEDULE 13G/A · W. Thorpe McKenzie 9.71%
- 2025-01-27 SCHEDULE 13G/A · John Simard 19.9%
- 2024-02-07 SC 13G/A · John Simard 19.9%
- 2024-02-07 SC 13G/A · Thomas Gut 12.86%
- 2024-02-07 SC 13G/A · W. Thorpe McKenzie 9.68%
- 2023-02-10 SC 13G · W. Thorpe McKenzie 9.87%
- 2023-02-10 SC 13G · John Simard 16.33%
- 2023-02-10 SC 13G · Thomas Gut 12.86%
- 2023-01-12 SC 13G · Lombard International Assurance S.A. 3.66%
- 2022-06-16 SC 13G · Thomas Gut 12.88%
- 2022-02-16 SC 13G · W. Thorpe McKenzie 9.81%
- 2022-02-16 SC 13G · John Simard 16.08%
- 2022-01-13 SC 13G · Lombard International Assurance S.A. 6.92%
- 2020-12-23 SC 13G/A · Bay Street Financial S.A. 2.89%
- 2020-02-14 SC 13G/A · John Simard 17.6%
- 2020-02-14 SC 13G/A · W. Thorpe McKenzie 11.6%
- 2020-02-13 SC 13G · Bay Street Financial S.A. 12.17%
- 2020-02-13 SC 13G/A · Rennes Fondation 0.27%
Loading sc13g_021616.htm…